Like n comment

Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy

The demand outlook for Biogen’s new Alzheimer’s drug appears strong despite lingering concerns about
Piper Sandler upgrades Biogen, says Alzheimer's drug demand will be strong despite controversy

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • YoshiTei
    ·2021-06-18
    help reply thanks
    Reply
    Report